This inventor holds 17 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 7 EPO patents, primarily in Glycosidase Inhibitors. Top assignee: Asceneuron Sa. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2025
Areas of Expertise:
Title: The Innovative Contributions of Awadut Gajendra Giri
Introduction
Awadut Gajendra Giri is a prominent inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on piperazine derivatives. With a total of 17 patents to his name, Giri has established himself as a key figure in the development of pharmaceutical ingredients.
Latest Patents
Giri's latest patents include the invention of acid addition salts of piperazine derivatives. This invention relates to the acid addition salts, as well as solid forms, such as polymorphic forms, which are useful as pharmaceutical ingredients and, in particular, as glycosidase inhibitors. Another notable patent involves succinate and fumarate acid addition salts of piperazine derivatives. This invention also focuses on the solid forms, including polymorphic forms, that serve as pharmaceutical ingredients and glycosidase inhibitors.
Career Highlights
Throughout his career, Giri has worked diligently to advance pharmaceutical science. His innovative approaches have led to the development of new compounds that have the potential to improve therapeutic outcomes. His work is characterized by a commitment to research and a passion for innovation.
Collaborations
Giri has collaborated with several talented individuals in his field, including Anna Quattropani and Santosh Shripad Kulkarni. These collaborations have further enhanced his research and contributed to the success of his inventions.
Conclusion
Awadut Gajendra Giri's contributions to the pharmaceutical industry through his patents on piperazine derivatives highlight his innovative spirit and dedication to improving healthcare. His work continues to inspire future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
